Success Metrics

Clinical Success Rate
88.0%

Based on 353 completed trials

Completion Rate
88%(353/401)
Active Trials
190(25%)
Results Posted
15%(54 trials)
Terminated
48(6%)

Phase Distribution

Ph phase_1
19
2%
Ph early_phase_1
10
1%
Ph phase_3
13
2%
Ph not_applicable
250
32%
Ph phase_4
7
1%
Ph phase_2
41
5%

Phase Distribution

29

Early Stage

41

Mid Stage

20

Late Stage

Phase Distribution340 total trials
Early Phase 1First-in-human
10(2.9%)
Phase 1Safety & dosage
19(5.6%)
Phase 2Efficacy & side effects
41(12.1%)
Phase 3Large-scale testing
13(3.8%)
Phase 4Post-market surveillance
7(2.1%)
N/ANon-phased studies
250(73.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.7%

353 of 427 finished

Non-Completion Rate

17.3%

74 ended early

Currently Active

190

trials recruiting

Total Trials

770

all time

Status Distribution
Active(244)
Completed(353)
Terminated(74)
Other(99)

Detailed Status

Completed353
Recruiting127
unknown96
Active, not recruiting63
Not yet recruiting50
Terminated48

Development Timeline

Analytics

Development Status

Total Trials
770
Active
190
Success Rate
88.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 110 (2.9%)
Phase 119 (5.6%)
Phase 241 (12.1%)
Phase 313 (3.8%)
Phase 47 (2.1%)
N/A250 (73.5%)

Trials by Status

unknown9612%
active_not_recruiting638%
completed35346%
enrolling_by_invitation41%
suspended30%
withdrawn263%
not_yet_recruiting506%
recruiting12716%
terminated486%

Recent Activity

Clinical Trials (770)

Showing 20 of 770 trialsScroll for more
NCT05877014Phase 3

Unipolar Versus Bipolar Interlocking in Humeral Shaft Fractures in Adults

Recruiting
NCT05675059Not Applicable

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Completed
NCT07734142

Mental Health Outcomes and Psychological Evaluation After Liver Transplantation

Not Yet Recruiting
NCT07067658Not Applicable

Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk

Recruiting
NCT06222099Not Applicable

The HEARTFELT Study

Recruiting
NCT07631026Not Applicable

Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery

Not Yet Recruiting
NCT02244411Not Applicable

Exercise and QUality Diet After Leukemia: The EQUAL Study

Completed
NCT07725146

Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire

Recruiting
NCT03835273

Oesophagectomy and Chest Wall and Respiratory Function

Terminated
NCT07172334

What is the Role of the Exposome in Pulmonary Hypertension

Not Yet Recruiting
NCT02164019Not Applicable

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Active Not Recruiting
NCT03006848Phase 2

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Completed
NCT01949662Phase 2

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Active Not Recruiting
NCT07094074Not Applicable

Exploratory Functional Assessment After Lower Limb Amputation: Locomotion, Balance, Energy Performance and Strategies for Adapting to Orthopaedic Devices

Not Yet Recruiting
NCT05108298Not Applicable

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Recruiting
NCT07639320Not Applicable

Benefits of Using Virtual Reality Preoperatively in Managing Anxiety During Outpatient Foot Bone Surgery

Terminated
NCT06955910

Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

Completed
NCT07668310Not Applicable

Effectiveness of PErcutaneous Ultrasound-guided Carpal Tunnel Release: a Non-inferiority Study With Surgery as Comparator

Terminated
NCT07658326

Preoperative Stress Assessment in Patients Undergoing Surgery for Rotator Cuff Tendinopathy

Recruiting
NCT07653828Not Applicable

Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected Application

Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
770